Print PDF

Pharmaceutical Compliance Congress 2025

McLean, VA
April 28-30, 2025

Your complete guide to mitigate risk: Stay on the pulse of enforcement trends, supercharge your best practice playbook and expand your network at PCC 2025.

Partner Dominick DiSabatino will be speaking on the panel "Patient Advocacy: New Growing Risk for Compliance?" on April 28 from 5:00-5:45 PM ET.

Panel Discussion Topics:

  • How are organizations managing Compliance surrounding patient advocacy and patient education groups?
  • Examining differing approaches on transfer of value in meals, speaker honorarium etc
  • Internal guidelines and what are they spending on patients, are they allowing alcohol etc?
  • How is this spend tracked, and by whom to make sure you don't pay patients "too much"?
  • Is there a cap for overall spend per patient/caregiver?
  • How is FMV determined?
  • What is the role of the Patient Advocate vs Patient or Caregiver?
  • How, if at all, does the analysis change post-approval vs. during research?

Partner Scott Liebman will be speaking on the panel "Law Firm Benchmarking Session - Chairs of Life Science Groups in Law Firms" on April 29 from 11:10 AM - 12:10 PM ET. 

Panel Discussion Topics:

  • What are the next generation of enforcement cases?
  • Where are companies focusing? Where are we seeing trends?
  • Insiders’ insight: investigations and types of issues companies are struggling with
  • Creative strategies being employed to increase market share: key risks and mitigation strategies
  • How are you seeing your clients utilizing outside counsel and has the role of outside counsel changed?

Click here to register.

Practice Areas

Industries

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.